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Understanding the interaction of anticancer drugs with model cell lines is important to elucidate the mode of action of these drugs as well
as to develop cost effective and rapid screening methods. Raman spectroscopy has been demonstrated to be a valuable technique for high
throughput, noninvasive analysis. The interaction of vincristine with a human lung adenocarcinoma cell line (A549) was investigated
using Raman micro spectroscopy. The results were correlated with parallel measurements from the MTT cytotoxicity assay, which
yielded an IC50 value of 0.10 ± 0.03 μM. The Raman spectral data acquired from vincristine treated A549 cells was analysed to
understand its interaction with the nucleus in the cell and elucidate DNA intercalation. The dose dependent spectral changes in the
nucleus are analysed by PLS-Jack knifing for the identification of the more significant changes associated with the mode of action of the
drug. Results are correlated with a similar dose dependent expression analysis of the bcl-2 protein, an anti-apoptotic protein associated
with DNA damage, in the vincristine treated A549 cells using flow cytometry. The results indicate the co-existence of two modes of
action, microtubule binding at low doses and DNA intercalation at high doses.

Introduction

The in vitro study of the interaction of anticancer drugs
with mammalian cells is important to elucidate the
mechanisms of action of the drug on its biological targets
40 and thereby maximise efficacy. Cancer cell lines can be a
good model to study the effects of these anticancer agents
and such in vitro studies are in accordance with the EU
policy of Reduction, Replacement and Refinement (RRR)
of the protection of animals used for experimental and
45 scientific
purposes (Directive 2010/63/EU). Another
concern is the requirement of a non-invasive, cost
effective, rapid screening technique which can analyse the
samples, ideally without any labelling. Raman micro
spectroscopy potentially provides these benefits 1. In
50 addition, Raman spectroscopy can provide high content
information, as it can examine spectral changes in the cell
membrane, cytoplasm and nucleus of the target cells
simultaneously and can differentiate the biochemical
interaction of external agents with the cell from its
2, 3
55 physiological response
.

This journal is © The Royal Society of Chemistry [year]

The potential of confocal Raman micro spectroscopy
(CRM) for the analysis of biological tissue 4 and the effect
of external agents on the cell 5-9 has been demonstrated.
Moreover, the technique, with its counterpart Fourier
60 transform infrared (FTIR) micro spectroscopy, is being
used to explore sub-cellular biochemical structure, as
demonstrated by its use in studies investigating the action
of various agents on biological macromolecules as well as
their interaction with cancer cells 1-3, 10-17.
65 The use of CRM in studying the biochemical effects of
established, commercially available anticancer drugs may
be helpful therefore in order to validate its use for the
evaluation of the novel anticancer agents. To this end, such
an approach was demonstrated for the action of cis-platin
2, 3
70 with lung cells in vitro
. The study utilized multivariate
regression and feature selection techniques to correlate
spectral changes with drug dose and cell viability, as
measured using a standard cytotoxic assay.
A proposed primary mode of action of vincristine is
75 through its binding to tubulin monomers in the cytoplasm,
which leads to a change in the dynamics of the microtubule
assembly and prevention of the formation of bi-polar
spindles 18, necessary for the proper segregation of the
duplicated chromosomes and ultimately cell division.
Journal Name, [year], [vol], 00–00 | 1

Additionally, however, vincristine has been reported to
interact directly with DNA in acellular studies, as observed
using techniques such as Atomic Force Microscopy 19,
Fluorescence image microscopy 20 and FTIR spectroscopy
21
5
, which indicate that it acts as an intercalator. The
combined evidence raises the question as to whether
vincristine causes cell death only by disturbing the
dynamics of the microtubule assembly or whether the
DNA damage caused by this anticancer agent also
10 contributes to its efficacy.
The purpose of this study is to further elucidate the
interaction of the drug on a cellular level, as well as the
cellular response pathways, using CRM to characterise
biochemical changes on the subcellular level. To support
15 the spectroscopic investigation, the expression of bcl-2
protein as a result of vincristine treatment is explored using
flow cytometry. Bcl-2 is an anti-apoptotic protein which is
generated as a direct result of DNA damage, and is thus
involved in the regulation of cell death and serves as an
22, 23
20 indicator of genotoxic stress to the cell
. The
comparison of the observations of changes to the Raman
signatures of nucleus of the A549 cells as a result of
vincristine exposure as compared to the unexposed control,
as well as the changes in the expression profile of bcl-2,
25 may lead to elucidation as to whether DNA damage
contributes to the mode of action of this anticancer agent.

30

Experimental
MTT assay
Vincristine was purchased from Sigma Aldrich, Ireland, in
the form of vincristine sulphate (V8388) and a stock
solution was prepared in distilled water. Working solutions
were prepared in the cell culture media.

MTT was obtained from Sigma Aldrich, Ireland. The MTT
assay was performed in triplicate according to a method
reported previously 24 with a slight modification. The
exposure of A549 cells to vincristine was done for 96hours, over a wide range of concentrations (0.01-10 μM) to
40 establish the half maximal inhibitory concentration (IC50)
and the appropriate range over which to conduct the
analysis.
35

The MTT measurement protocol was as follows. Cells
were cultured in 96-well plates (Nunc, Denmark) at a
3
45 density of 2  10 cells per well in Dulbecco’s Modified
Eagle Medium-F12 (DMEM) with all the supplements as
listed above. After 24 hrs of initial cell attachment, the
plates were washed with 100 μl/well phosphate buffered
saline (PBS) and were treated with varying concentrations
50 of vincristine in the range of 0.01 μM -10 μM (including a
separate unexposed control sample). Following a 96-hour
exposure period, the cells were rinsed with PBS and 100 μl
of fresh medium (without supplements) were added to each
well. A volume of 10 µl of MTT (5mg/ml) prepared in
2 | Journal Name, [year], [vol], 00–00

PBS was then added to each well and the plates were
incubated for 3 hrs at 37 °C in a 5% CO2 humidified
incubator. After this incubation period, the medium was
discarded, the cells were washed with 100 μl of PBS and
100 μl of Dimethyl Sulphoxide (DMSO) were added to
60 each well to extract the dye. The plates were then shaken
240 times per minute for 10 min and the absorbance was
measured at 570 nm using a micro plate reader (Tecan
Genios, Grodig, Austria). Six replicate wells were used for
each exposure.
55

65

Raman micro spectroscopy
In this work, CRM was conducted with a Horiba JobinYvon, LabRam HR800 instrument using a 785 nm laser as
source. Spectra were taken in the range from 600 cm-1 to
-1
70 1800 cm
with a confocal hole diameter of 100μm. A x100
water immersion objective was used to focus the laser on
the sample, immersed in 0.9% saline, yielding a spot size
of ~1 µm.
For CRM, cell samples were cultured on quartz substrates
according to a protocol outlined elsewhere 9. Briefly,
quartz coverslips were coated with a 2% w/v gelatin-water
solution and maintained at 4 °C for 6 hrs to allow
polymerization of the gelatin on the substrate.
Subsequently, 2.5  103 A549 cells were attached to the
80 substrates for a 48 hour period, and were exposed to
vincristine concentrations in the range of 0.01 μM -10 μM
for a 96-hour period (together with a non-exposed control
sample). After the exposure period, the cells were fixed in
4% formalin for 10 minutes and were stored in 0.9 %
85 physiological saline solution at 4 °C until the Raman
analysis was performed 25. All samples were prepared in
triplicate.
For spectral acquisition, the laser power was
approximately 70 mW at the sample. Spectra were taken in
-1
90 the range from 600 cm
to 1800 cm-1 with a confocal hole
diameter of 100μm. A 100 water immersion objective
was used to focus the laser on the sample, immersed in
0.9% saline, yielding a spot size of ~1 µm. Multiple
spectra were recorded from the nuclear portion, visually
95 identified using the optical microscope of the instrument,
of a total of 60 cells at each exposure level. The point
spectra were recorded from the cell nuclei of the sixty
different A549 cells for control as well as exposed
samples.
75

100

Data analysis
All spectral analysis was performed in the Matlab 7.2 (The
Mathworks Inc.) environment employing the PLS Toolbox
105 5.0.3
(Eigenvector Research, Wenatchee, WA) and
algorithms developed in-house. Subsequently, the spectra
were smoothed with a Savitsky-Golay filter (order 5, 13
point window), and the quartz signal background was
subtracted using algorithms developed in-house. Prior to

This journal is © The Royal Society of Chemistry [year]

analysis, the spectra were also vector normalized and a
fifth order polynomial was fitted to the spectra to remove
any residual spectral baseline. Outlying spectra were
removed using Grubb’s filtering 26.
5 PLS Jack-knifing was employed as a multivariate feature
selection technique 27-29. The PLS regression algorithm
seeks to develop a model that relates the spectral data (Xmatrix) to a series of targets (Y-matrix, e.g. concentration
of reaction product or analyte) according to the equation
10 Y=XB+E, where B is a matrix of regression coefficients
and E is the regression residual. The Y-matrix here
consisted of values of the concentration of vincristine to
which the cells were exposed, or the measured level of cell
viability from the MTT assay. The PLS Jack-knifing
15 method developed by Westad and Martens was then used
to determine the spectral features that were statistically
significant at a particular level of confidence using ttesting of the regression coefficients, B 29. The Raman
band assignments used in interpretation of the spectral
9, 15, 30-32
20 features were taken from the literature
.

60

65

The expression analysis of the bcl-2 protein in A549 cells
due to the action of the vincristine was performed using a
Partec Flow Cytometer (Partec UK Limited, U.K.) and the
data analysis was performed using Summit software
(Version 4.3, DAKO, Denmark).

Results
IC50 for vincristine

The MTT results for the cytotoxicity measurement of
vincristine in A549 cells are presented in Figure 1. The
70 level of viability in each sample was normalised to that of
the control sample. The Inhibitory Concentration (IC50)
value was derived from the data by a fit of the Hill
equation, f(x) = min + (max-min)/(1+(x/IC50)^n) and found
to be 0.10±0.03 μM. The primary purpose of the MTT
75 assay was to determine the exposure range over which the
maximum variation occurs in the cellular response, and
thus the optimum range to probe the associated changes to
the spectral response.

Flow cytometry
For the culture of A549 cells, the materials and protocols
used were the same as those described above for Raman
spectroscopy measurements. The bcl-2 antibody labelled
by FITC with an IgG1 isotype control was purchased from
BD biosciences (BD 556357). The cytoperm/ cytofix
fixation/ permeabilization kit was purchased from BD
30 biosciences (BD 554714).
The A549 cells were cultured in tissue culture flasks
(Nunc, Denmark) at a density of 1  105 cells in DMEMF12 medium with all the supplements as described earlier.
After 24 hrs of initial cell attachment, the plates were
35 washed
with PBS and were treated with varying
concentrations of vincristine in the range from 0.01 μM10μM (including a separate unexposed control sample).
Following a 96-hour exposure period, the cells were
trypsinised and collected in an Eppendorf, 1x10 6 cells per
40 sample. The cells were washed twice with ice cold
Dulbecco's Phosphate-Buffered Saline (DPBS) buffer
(containing protein and NaN3), gently resuspended and
centrifuged (250-300 g). The fixation buffer (250μl) was
added to each sample, and the process was followed by
45 gentle pipetting and incubation for 30 minutes at 4 ˚C. The
fixed cells were washed and suspended in the stain buffer.
This was followed by the addition of 100 μl of the
permeabilization buffer and incubation for 15 minutes at
room temperature. The samples were then washed twice
50 with 1ml of the perm wash buffer and centrifuged at 250300 g for 5 minutes at 4 ˚C, and the cells were suspended
in 50 μl of the perm wash buffer and the diluted antibody
was added. This was followed by incubation of the
samples for 60 minutes, on ice and in the dark. Then cells
55 were washed twice with the perm wash solution to remove
the unbound antibody. The tubes were inverted and blotted
to remove the supernatant. The samples were resuspended
in stain buffer and analyzed by flow cytometry.

1.0

25

This journal is © The Royal Society of Chemistry [year]

Normalised Viability

0.8

0.6

0.4

0.2

0.0
0.001
80

0.01

0.1

1

Vincristine Concentration (M)

Figure 1 Viability of the A549 cells measured by MTT absorbance at 96
hours after exposure to vincristine. Error bars denote the standard error on
the mean at each concentration.
85

Interaction of vincristine with the nucleus of A549 cells

90

To identify any biochemical changes caused by the direct
action of vincristine on the nucleus, the Raman spectra of
the nucleus of A549 cells exposed to the range of
concentrations of vincristine were recorded. The nuclear

Journal Name, [year], [vol], 00–00 | 3
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spectra of the mean control, and vincristine exposed
samples are shown in Figure 2. The major changes
observed in the spectra of the nucleus of A549 cells are in
the Raman bands of the DNA bases, including thymine
-1
-1
-1
5 (669 cm and 1253 cm ), adenine (728 cm ), guanine
-1
-1
(1317 cm ) and cytosine (783 cm ). These changes can be
attributed to the action of the vincristine within the nucleus
of the A549 cells and specifically due to interaction with
the DNA. As the concentration of the drug exposure
10 increases, a decrease in the intensities of the bands
associated with the DNA bases is observed. This is
consistent with the results of the intercalation of the
ethidium bromide, a well known DNA intercalator, into
calf thymus DNA studied by Raman spectroscopy 33.
21
15 Conversely,
have reported an increase in the intensities
of the bands due to DNA bases while investigating the
effect of very high concentrations, ranging from 200-300
μM, of vincristine on calf thymus DNA, acellularly, with
the help of FTIR spectroscopy. It should be noted,
20 however, that these concentrations are significantly higher
than the maximum of the range employed in this study (10
μM), and the clinically relevant IC50 (0.1 μM). The
decrease in the intensities of the vibrational features
ascribed to these DNA bases and most importantly the
25 conformational changes of the B-form DNA into A-form,
as indicated by the continuous decrease in the intensity of
the Raman band at 827 cm-1 and concomitant increase in
the intensity of the A-form DNA (811 cm-1), due to the
action of vincristine, provides evidence of intracellular
30 intercalation of vincristine into the DNA. Moreover, in the
control spectra of the nucleus of A549 cells, the CH 2
scissoring mode, observed as a sharp band at 1422 cm-1, is
considered as an important Raman marker of the B-form
DNA and is found to be much more broader and lower in
34
35 peak intensity in the A-form DNA
. This trend is clearly
observable in the decreased contributions of this band in
exposed samples in Figure 2, again indicating
conformational changes in the B-form DNA in favour of
the A-form.
40

Interestingly, in comparison to the effects on the nuclear
Raman spectrum as a result of exposure to cisplatin, a
known DNA groove binder, 2, the changes observed in the
conformation of the B-form of DNA, the dominant form of
45 cellular
DNA, are more prominent. These changes,
including decreases in the Raman intensities of the bands
due to DNA bases and changes in the DNA conformation
are the important Raman markers of DNA intercalation 33,
35-37
. Changes in the phosphodiester linkages, the O-P-O
50 stretching vibrations of the DNA, are also observed at
1095 cm-1 along with a shift towards lower wavenumber at
the higher concentrations including 3 and 10 μM. These
changes indicate that vincristine also has the ability to bind
to the DNA externally, in addition to its insertion into the
21
55 DNA helix
, as observed in the case of cisplatin studies 2.
Raman bands related to proteins are also observed,
including those at 699 cm-1 and 718 cm-1, 879 cm-1, 1556
cm-1 (tryptophan ring breathing), 1265 cm-1 (amide-III, 4 | Journal Name, [year], [vol], 00–00

helix), 1302 cm-1 (CH2 deformation), and 938 cm-1 (C-C
-1
60 stretching), 959 cm
(CH3 deformation) and 1060 cm-1 (CN stretching). The intensities of all these Raman bands
increase as a result of an increase in the concentration of
the exposures of the vincristine, particularly at the higher
concentrations of this anticancer drug. This may be due to
65 the fact that, after the conformational changes caused in
the DNA by the anticancer drug binding, high mobility
group proteins bind to the intercalation site and prevent
repair by nuclease enzyme excision 38. Furthermore, the
proteins which are present in the nucleus, essentially
70 required for the DNA strand packaging, may be more
exposed due to the DNA strand opening which is caused
by the intercalation of the vincristine.
It should be noted that the Raman spectral changes
observed in Figure 2 and discussed above can not
75 unambiguously be attributed specifically to either the
direct chemical binding of the vincristine to the DNA in
the nucleus of the A549 cells or the subsequent
physiological response of the cells to the drug. Therefore,
PLS-Jack knifing was employed in an attempt to
80 differentiate the chemical and the physiological effect of
the drug by regressing the Raman spectral data from the
nucleus of A549 cells against the exposure concentrations,
compared to a similar regression against the cell viability
end points 2.
85

PLS-Jack knifing analysis was carried out on the Raman
spectral data from the nucleus of control and exposed
A549 cells (over the full dose range) to further understand
and confirm the mode of action of vincristine as an
90 intercalative
agent with DNA, and to identify the
fingerprints of this interaction within the cellular spectra of
exposed cells. The regression co-efficients were obtained
by PLS-Jack knifing for separate regressions against
vincristine concentrations and against the cell viability, as
95 determined using the MTT assay. To reveal spectral
changes that are most statistically significant with respect
to regression against either endpoint, a t-test (p<0.001) was
applied to the PLS-Jack knifing results, and the spectral
features identified by this process are highlighted by
100 vertical bands in Figure 3. The spectral bands identified
and their assignments are tabulated in the Supplementary
Information. The PLS regression of the nuclear data
against vincristine concentrations identified a number of
spectral features, labelled in Figure 3 A, related to the
-1
105 DNA bases, including guanine (1209-1211 cm , 1289-1
-1
1309 cm , 1320-1322 cm ), thymine (673-678 cm-1, 733737 cm-1, 1251-1257 cm-1, 1378-1381 cm-1) and cytosine
(773-778 cm-1, 1166-1173 cm-1, 1298-1309 cm-1). These
features are identified only in the regression against the
110 concentration
of the vincristine. Moreover, changes
associated with the phosphodiester linkage, O-P-O of the
DNA, are also highlighted (1062-1065 cm-1 and 1075-1090
cm-1), confirming the indications from Figure 2 that
vincristine, in addition to the intercalation mode of action,
115 can also bind to the DNA externally.

This journal is © The Royal Society of Chemistry [year]

The changes which are observed only in the regression of
the nuclear data against cell viability, Figure 3 (B), include
C-C stretching of tyrosine residues (637-643 cm-1),
tryptophan ring breathing (696-700 cm-1), amide-III (1250-1
5 1256 cm ), CH in plane bending of tyrosine (842, 844 cm
1
-1
-1
, 1176-1177 cm ) and CH deformation (1340-1343 cm ),

which can be assigned to proteins. These features
potentially originate from the high mobility group proteins
which are activated to prevent further damage to the cell
38
10 and to repair by nuclease enzyme excision
.
Comparing the regression co-efficients obtained by PLSregression analysis of the Raman spectral data against the

15

Figure 2: Mean spectrum of the nucleus of control and exposed A549 cells to 0.01-10 M vincristine.

This journal is © The Royal Society of Chemistry [year]
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Figure 3 Feature selection in PLS-Jack knifing of Raman spectra of the A549 cell nucleus against (A) vincristine concentrations and (B) against cellular
viability. The shaded areas in grey denote the statistically significant features selected using PLS Jack-knifing with a t-test (p<0.001) of regression
coefficients (shown in red with associated standard error shaded about them). This demonstrates that the spectral data contains features associated with the
biochemical effect of vincristine on the nucleus (A) and the associated effect on cellular viability (B).
10

6 | Journal Name, [year], [vol], 00–00
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concentrations of the exposures of the vincristine (which
highlight the primary biochemical effect of the action of
the agent) with those obtained via regression against cell
viability (which highlight biochemical markers of the
5 change in the viability of the cell), very different spectral
features are selected as being statistically significant. This
allows the differentiation of the biochemical changes
caused in the A549 cells due to the DNA binding of the
vincristine from the physiological response of the cells. It
10 is noted that the PLS-Jack-knifing identifies a range of
spectral features of relevance in the regression against each
set of targets, the relevance of which appears statistically
justified by the application of the t-test of the regression
coefficients. Karaman et al. have however demonstrated
15 that, in comparison to Sparse PLSR, the PLS- Jack knifing
method was prone to selecting uninformative variables 39.
Ultimately the accuracy, sensitivity and specificity of the
method should be validated using simulated datasets 12.
It is also noted that as a function of concentration, the cells
which remain alive and are therefore probed by CRM
potentially include those which have not yet been exposed,
or have not yet responded to the drug, at low
concentrations and potentially cells which are immune at
25 higher concentrations. Nevertheless, the MTT assay is a
measure of mitochondrial activity of the cell population,
and the spectral markers identified by regression of the
CRM data against the MTT target should provide a similar
measure of this as an indication of viability for in vitro
30 screening, in a label free manner. Ideally, to examine the
true cellular response, CRM should be performed on live
cells with subcellular resolution in a time resolved fashion.
20

Expression of bcl-2 protein in A549 cells treated with
vincristine analysed by Flow cytometry
Raman spectroscopic analysis of the nucleus of exposed
cells clearly indicates the interaction of vincristine with
nuclear DNA. The bcl-2 protein is an anti-apoptotic protein
40, 41
, and is involved in blocking DNA damage induced
42, 43
40 apoptosis
. Changes in the expression of bcl-2 after
exposure of the A549 cells to vincristine would indicate
the involvement of the DNA damage pathway in the mode
of action of the drug. Enhanced expression would point
towards the development of resistance towards DNA
45 damage induced cell death and decreased expression vice
versa. Therefore, simultaneous observation of bcl-2 as a
result of DNA damage and reduced cellular viability would
point towards alternative mechanisms of cell death.
The results of flow cytometry for the expression of bcl-2
50 protein in A549 cells as a result of the treatment with
various concentrations of vincristine ranging from 0.01
μM-10 μM, are shown in Figure 4. The results show that,
due to the exposure of different concentrations of
vincristine to A549 cells, the level of bcl-2 protein
55 compared
to control increases steadily up to a
concentration of 5 µM, whereupon it decreases. These
results indicate the involvement of the bcl-2 protein and
therefore DNA damage in the mode of action of
35

This journal is © The Royal Society of Chemistry [year]

vincristine. A549 cells do not intrinsically express marked
levels of bcl-2 protein as shown by 23, 44. The up-regulation
of the bcl-2 protein is therefore a response of the cell to the
external agent which causes damage to the nuclear DNA.
A similar expression profile, up regulation followed by
down regulation of the bcl-2 protein, was observed while
65 studying the effect of the anaesthetic halothane, considered
as a DNA damaging agent, on A549 cells and this
expression profile has been reported to be responsible for
the resistance to apoptosis at low doses, whereas induced
apoptosis due to DNA damage becomes prominent upon
23
70 down regulation of bcl-2 at high doses
. In the current
study, the Raman spectral data also indicates that
vincristine binds to the cellular DNA by intercalation, so
here bcl-2 up regulation may be in response to the DNA
damage caused by the drug 45. This may lead to the
75 conclusion
that vincristine also binds to DNA by
intercalation, causes up regulation of bcl-2, whose antiapoptotic function helps to delay the response of the cells
at low doses (development of resistance). The bcl-2
expression is observed to decrease at doses > 5 µM,
80 however, indicating that above these doses the cells are
susceptible to apoptosis induced by DNA damage.
The Raman results give a clear indication that the
documented acellular interactions of vincristine with DNA
also occur intracellularly. However, the bcl-2 results
85 indicate a resistance to apoptosis induced by DNA damage
at vincristine doses <5 µM. Critically however, this dose is
significantly higher than the IC50 value of 0.10 ± 0.03 μM,
measured by the MTT assay. Therefore, the dominant
mechanism of cell death at lower doses cannot be ascribed
90 to DNA damage, but rather to the mechanism of tubulin
binding leading to a change in the dynamics of the
microtubule assembly and prevention of the formation of
bi-polar spindles 18.
60

95

Figure 4 Expression level of bcl-2 shown as increase in the fluorescence,
due to the treatment of different concentrations of vincristine in A549
cells determined by flow cytometry.

Journal Name, [year], [vol], 00–00 | 7

Conclusion
The Raman analysis confirms that vincristine interacts with
the nuclear DNA resulting in significant changes to the
5 spectroscopic markers of DNA which are characteristic of
both intercalation and external binding. Changes observed
in the DNA related features include those of cytosine (783
cm-1), guanine (1318 cm-1), thymine (1375 cm-1), O-P-O of
DNA (1095 cm-1). Notably, the changes in the B-form
-1
10 DNA (827 cm ) in favour of A-form conformation and Bform DNA (1422 cm-1) are prominent and systematic as a
function of vincristine exposure. These changes can be
taken as the Raman markers of DNA intercalation.
Expression of bcl-2 in A549 cells as a result of exposure to
15 vincristine is found to be concentration dependant and
increases with increasing concentration to a maximum,
whereafter levels are reduced at higher doses. The upregulation of bcl-2 is the response of the cell to the external
agent which causes damage to the DNA and affects an
20 inhibition of apoptosis. In the current study, the Raman
spectral data indicated that vincristine binds the cellular
DNA by intercalation, so here bcl-2 up regulation is in
response to the DNA damage caused by the drug and
confirms the findings of the Raman study for the
25 interaction of this drug with nucleus of the A549 cells.
Nevertheless, the MTT assay clearly indicates loss of
viability at these doses, pointing to microtubule damage as
the primary mode of action in this region. The study
demonstrates the potential of Raman spectroscopy, not
30 only for the fingerprinting and screening of cellular
responses but for the elucidation of mechanisms of action
of external agents.
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Supplementary information:
15

Spectral ranges (cm-1)

assignments

621-626

C-C twisting of phenyl

629-633

C-C stretching

635-637

C-C stretching

637-643

C-C stretching of tyrosine residues

655-656

alanine

673-678

thymine

696-700

tryptophan ring breathing

703-704

tryptophan

708-711

tyrosine

719-727

Adenine/tryptophan

733-737

thymine

748-750

thymine

763-766

thymine

769-773

alanine

773-778

tryptophan

784-795

cytosine

797-808

O-P-O of DNA (A-form)

828-829

O-P-O of DNA (B-form)

842-844

CH in plane bending of tyrosine

849-857

C-C stretching

861-864

tryptophan

893-898

Deoxiribose of DNA

904-906

valine

936-939

C-C stretching

944-947

valine

1000-1007

Phenyl alanine
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1021-1026

CH in plane bending

1030-1033

CH in plane bending

1055-1058

C-N stretching

1062-1065

O-P-O of the DNA

1075-1090

O-P-O of the DNA

1114-1121

C-N stretching

1142-1148

C-C stretching

1166-1173

cytosine

1176-1177

CH in plane bending of tyrosine

1194-1196

tyrosine

1209-1211

guanine

1251-1257

thymine

1250-1256

amide-III

1261-1261

Amide-III β-sheet

1263-1271

Amide-III β-sheet

1276-1280

Amide-III α-sheet

1289-1309

cytosine

1320-1322

guanine

1331-1332

tryptophan

1347-1360

CH3 stretching

1340-1343

CH deformation

1378-1381

thymine

1424-1428

CH deformation

1453-1461

CH deformation

1468-1470

histidine

1503-1505

C=C stretching

1545-1559

tryptophan

1566-1572

tryptophan

1596-1597

C=C bending

1631-1633

histidine

1643-1645

C=C stretching

1663-1665

amide-I
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1702-1709

thymine

1727-1731

C=O ester

1783-1786

C-C bending
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